Results
1 -
10 of
11
(Click
here to explore results)
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 10 Repurposing Approved Drugs to Block Highly Pathogenic Emerging Viruses. B. Mercorelli, A. Loregian
, 2022
, Pages 232-255
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, CHAPTER 15 COVID-19 Pharmacotherapy – Present and Future. Deepak Kumar, Ravi Mangalia, Mahadev Meena, Varatharajan Sakthivadivel, Gopal Krishna Bohra, Stafford Warren
, 2022
, Volume 1
, Pages 412-454
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets. Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, CHAPTER 6 Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials. Ssang-Goo Cho, Claude Hughes, Iyer Mahalaxmi, Mohana Devi Subramaniam, Balachandar Vellingiri, Stafford Warren
, 2022
, Volume 1
, Pages 136-164
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Subject Index
, 2022
, Pages 280-290
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, Contents
, 2022
, Volume 2
, Pages P019-P030
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, Contents
, 2022
, Volume 1
, Pages P019-P030
- Nuclear Magnetic Resonance: Volume 41, NMR of liquid crystals and micellar solutions. Gerardino D’Errico, Luigi Paduano
, 2012
, Volume 41
, Pages 429-479
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 1, CHAPTER 16 Knowledge from Human Relevant Cell, Tissue and Mathematics-based Methods as Key Tools for Understanding COVID-19 Dynamics, Kinetics, Symptoms, Risk Factors and Non-conventional Treatments. Sandra Coecke, Amalia Munoz, Vito D'Alessandro, Francesca De Bernardi, Pietro Romeo, Felipe Torres, Georgina Harris, Surat Parvatam
, 2022
, Volume 1
, Pages 455-525